SSGSX | VSVIX | SSGSX / VSVIX | |
Total Expense Ratio | 1.26 | 1.07 | 118% |
Annual Report Gross Expense Ratio | 1.26 | 1.07 | 118% |
Fund Existence | 26 years | 20 years | - |
Gain YTD | -8.400 | -9.734 | 86% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.52B | 978M | 565% |
Annual Yield % from dividends | 0.52 | 1.74 | 30% |
Returns for 1 year | -8.36 | -16.93 | 49% |
Returns for 3 years | -3.90 | -16.21 | 24% |
Returns for 5 years | 21.72 | 16.62 | 131% |
Returns for 10 years | 7.10 | -15.44 | -46% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CMDT | 26.70 | 0.41 | +1.56% |
PIMCO Commodity Strategy Act Exc-Trd Fd | |||
XSVN | 47.17 | -0.16 | -0.33% |
BondBloxx Bloomberg SevenYrTrgDurUSTrETF | |||
VMBS | 45.69 | -0.18 | -0.39% |
Vanguard Mortgage-Backed Secs ETF | |||
EOS | 23.36 | -0.10 | -0.43% |
Eaton Vance Enhance Equity Income Fund II | |||
IBBQ | 21.39 | -0.20 | -0.93% |
Invesco Nasdaq Biotechnology ETF |